Intravitreous (IVT) injection is the fastest growing procedure in ophthalmology. The number of IVT injections performed in the United States, estimated from Medicare procedure codes, increased from fewer than 3000 injections per year in 1999 to more than 1 million injections in 2008, and the number of injections will continue to increase given the aging population and the expanding indications.1
Kim SJ, Chomsky AS, Sternberg P. Reducing the Risk of Endophthalmitis After Intravitreous Injection. JAMA Ophthalmol. 2013;131(5):674–675. doi:10.1001/jamaophthalmol.2013.2914
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: